When pharmaceutical companies are ready to ramp up the output of their products, they turn to BioVectra.
Organization: Moderna
The Short Report – October 26, 2022: NSERC prizes; Canada’s role in NASA’s climate science satellite mission; an EU-Canada quantum project, and more.
François-Philippe Champagne announces this year’s NSERC Prize winners; Canada’s contribution to the NASA-led climate science satellite mission; establishing an intercontinental network for quantum communication, and more.
Moderna to build vaccine production facility as part of new federal biomanufacturing strategy
The U.S.-based vaccine manufacturer Moderna Inc. will be building a plant in Canada after signing a memorandum of understanding with the Canadian government this week.
The Short Report – August 11, 2021: A feasibility study to export blue hydrogen from Alberta to Asia, tech to reduce pesticide use, and more
Petronas Energy and Itochu Corporation consider exporting blue hydrogen from Alberta, a UWaterloo engineering team gets backing to secure Canada’s critical energy infrastructure, FedNor grows up, and more.
Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa
Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.
NGen joins $10-million effort to bolster manufacturing capacity for a COVID-19 vaccine
The NGen supercluster has awarded $27 million in funding for 12 advanced manufacturing projects that can supply critical health care products to combat COVID-19. The funding includes $5 million for Providence Therapeutics and partner Northern RNA to establish manufacturing capacity in Calgary for Providence’s made-in-Canada vaccine.
Precision NanoSystems receives federal support to build $50 million biomanufacturing facility in Vancouver
New plant expected to produce 240 million vaccine doses every year starting in 2023.
The Short Report – Oct. 14, 2020: CIHR signs MOU to support Inuit-led health research, Health Canada accepts rolling submission for a COVID-19 vaccine candidate, and more
Facedrive’s TraceSCAN technology garners interest among companies globally; Canada’s National Digital Research Infrastructure Strategy has its first researcher council, and a new consortium takes shape to accelerate the commercialization of quantum computing.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...